Structure-based drug design of 1,3,6-trisubstituted 1,4-diazepan-7-ones as selective human kallikrein 7 inhibitors

被引：8
|
作者：
Murafuji, Hidenobu [1 ]
Sakai, Hiroki [1 ,2 ]
Goto, Megumi [1 ,2 ]
Oyama, Yoshiaki [1 ]
Imajo, Seiichi [1 ]
Sugawara, Hajime [1 ]
Tomoo, Toshiyuki [1 ]
Muto, Tsuyoshi [1 ]
机构：
[1] Asubio Pharma Co Ltd, Chuo Ku, 6-4-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan
[2] Daiichi Sankyo Co Ltd, Shinagawa R&D Ctr, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2018年 / 28卷 / 08期
关键词：
Atopic dermatitis; Serine protease; Kallikrein; 7; inhibitor; 1,4-Diazepan-7-one; Structure-based drug design; EPIDERMAL BARRIER DYSFUNCTION; ATOPIC-DERMATITIS; STRATUM-CORNEUM; SERINE PROTEASES; DESQUAMATION; EXPRESSION; SKIN;
D O I：
10.1016/j.bmcl.2018.03.011
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A novel series of 1,3,6-trisubstituted 1,4-diazepan-7-ones were investigated as human kallikrein 7 (KLK7, stratum corneum chymotryptic enzyme) inhibitors. Based on the X-ray co-crystal structure of compound 1 bound to human KLK7, the derivatives of this scaffold were designed, synthesized, and evaluated. Through structure-activity relationship studies focused on the side chain located in the prime site region of the enzyme, representative compounds 15, 33a, and 35a were identified as highly potent and selective inhibitors of human KLK7. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1371 / 1375
页数：5
相关论文
共 50 条
  • [41] Discovery of selective Mcl-1 inhibitors via structure-based design and structure-activity relationship analysis
    He, Nianzhe
    Liu, Peng
    Wang, Ziqian
    Guo, Zongwei
    Yan, Xinxin
    Chen, Hongbo
    Zhang, Zhichao
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 512 (04) : 921 - 926
  • [42] SYNTHESIS AND STRUCTURE OF 7-METHYL-AND 7-PHENYL1-1,2,3,4-TETRAHYDRO-1,4-DIAZEPIN-5-ONES
    HOFMANN, CM
    SAFIR, SR
    JOURNAL OF ORGANIC CHEMISTRY, 1962, 27 (10): : 3565 - &
  • [43] Probing the Acceptor Active Site Organization of the Human Recombinant β1,4-Galactosyltransferase 7 and Design of Xyloside-based Inhibitors
    Saliba, Mineem
    Ramalanjaona, Nick
    Gulberti, Sandrine
    Bertin-Jung, Isabelle
    Thomas, Aline
    Dahbi, Samir
    Lopin-Bon, Chrystel
    Jacquinet, Jean-Claude
    Breton, Christelle
    Ouzzine, Mohamed
    Fournel-Gigleux, Sylvie
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (12) : 7658 - 7670
  • [44] Structure-Based Drug Design of 2-Amino-[1,1′-biphenyl]-3-carboxamide Derivatives as Selective PKMYT1 Inhibitors for the Treatment of CCNE1-Amplified Breast Cancer
    Wang, Chaofan
    Fang, Yan
    Zhou, Ziqin
    Liu, Zhuoheng
    Feng, Fang
    Wan, Xuan
    Li, Yan
    Liu, Shuang
    Ding, Jian
    Zhang, Zhi-Min
    Xie, Hua
    Lu, Xiaoyun
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (17) : 15816 - 15836
  • [45] Discovery of potent, orally bioavailable ERK1/2 inhibitors with isoindolin-1-one structure by structure-based drug design
    Ji, Dezhong
    Zhang, Lingzhi
    Zhu, Qihua
    Bai, Ying
    Wu, Yaoyao
    Xu, Yungen
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 164 : 334 - 341
  • [46] Structure-Based Design of β1i or β5i Specific Inhibitors of Human Immunoproteasomes
    de Bruin, Gerjan
    Huber, Eva M.
    Xin, Bo-Tao
    van Rooden, Eva J.
    Al-Ayed, Karol
    Kim, Kyung-Bo
    Kisselev, Alexei F.
    Driessen, Christoph
    van der Stelt, Mario
    van der Marel, Gijsbert A.
    Groll, Michael
    Overkleeft, Herman S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (14) : 6197 - 6209
  • [47] Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy
    Gibson, Tony S.
    Johnson, Benjamin
    Fanjul, Andrea
    Halkowycz, Petro
    Dougan, Douglas R.
    Cole, Derek
    Swann, Steven
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (08) : 1709 - 1713
  • [48] STRUCTURE-BASED DRUG DESIGN OF NONPEPTIDIC P-2 SUBSTITUENTS FOR HIV-1 PROTEASE INHIBITORS
    KALISH, VJ
    TATLOCK, JH
    DAVIES, JF
    KALDOR, SW
    DRESSMAN, BA
    REICH, S
    PINO, M
    NYUGEN, D
    APPELT, K
    MUSICK, L
    WU, BW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (07) : 727 - 732
  • [49] Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy
    Gibson, Tony
    Johnson, Benjamin
    Fanjul, Andrea
    Halkowycz, Petro
    Dougan, Douglas
    Cole, Derek
    Swann, Steve
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [50] Identification of a novel chemotype of ASK1 inhibitors for heart failure utilizing structure-based drug design
    Chambers, Alison
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
12345